ArticleInternational journal of molecular sciences2018

The Combinational Use of CRISPR/Cas9 and Targeted Toxin Technology Enables Efficient Isolation of Bi-Allelic Knockout Non-Human Mammalian Clones.

Satoshi Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.